The Cancer Research Institute Associate Board is a group of young leaders dedicated to advancing cancer immunotherapy research. Members lend professional expertise and diverse talents to develop social events, assist with fundraising initiatives, and cultivate individual and corporate relationships.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
TESLA initiative scientists identified five keys important for the immune system’s ability to respond against abnormal tumor neoantigens.
This October for Breast Cancer Awareness Month, we look at new treatments, new research, and how we’re working toward a future immune to breast cancer.